DK0438566T3 - Substans P-antagonister - Google Patents

Substans P-antagonister

Info

Publication number
DK0438566T3
DK0438566T3 DK90912128.7T DK90912128T DK0438566T3 DK 0438566 T3 DK0438566 T3 DK 0438566T3 DK 90912128 T DK90912128 T DK 90912128T DK 0438566 T3 DK0438566 T3 DK 0438566T3
Authority
DK
Denmark
Prior art keywords
amino acid
acid residue
peptide
active site
analog
Prior art date
Application number
DK90912128.7T
Other languages
English (en)
Inventor
David H Coy
Jacques-Pierre Moreau
Original Assignee
Univ Tulane
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Tulane filed Critical Univ Tulane
Application granted granted Critical
Publication of DK0438566T3 publication Critical patent/DK0438566T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/22—Tachykinins, e.g. Eledoisins, Substance P; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK90912128.7T 1989-08-16 1990-08-16 Substans P-antagonister DK0438566T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39472789A 1989-08-16 1989-08-16

Publications (1)

Publication Number Publication Date
DK0438566T3 true DK0438566T3 (da) 1996-11-11

Family

ID=23560172

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90912128.7T DK0438566T3 (da) 1989-08-16 1990-08-16 Substans P-antagonister

Country Status (15)

Country Link
EP (1) EP0438566B1 (da)
JP (1) JPH04502922A (da)
AT (1) ATE143372T1 (da)
CA (1) CA2039175A1 (da)
CZ (2) CZ285319B6 (da)
DD (1) DD298411A5 (da)
DE (1) DE69028692T2 (da)
DK (1) DK0438566T3 (da)
ES (1) ES2094160T3 (da)
GR (1) GR900100613A (da)
HU (1) HUT65465A (da)
IE (1) IE77033B1 (da)
PT (1) PT95016B (da)
SK (1) SK402890A3 (da)
WO (1) WO1991002745A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5410019A (en) * 1987-09-24 1995-04-25 The Administrators Of The Tulane-Educational Fund Therapeutic peptides
FR2680174A1 (fr) * 1991-08-05 1993-02-12 Michelot Robert Nouveaux composes peptidiques, inhibiteurs de l'adsorption du virus hiv sur ses cellules cibles.
EP1082959A1 (en) 1991-09-20 2001-03-14 Glaxo Group Limited NK1 Antagonists for the treatment of depression
US6492330B1 (en) 1996-08-16 2002-12-10 National Institute Of Immunology Antiangiogenic drugs
US6156725A (en) * 1996-08-16 2000-12-05 National Institute Of Immunology Drug for the treatment of cancer
EP0835662B1 (en) * 1996-10-08 2001-11-14 National Institute of Immunology A drug for the treatment of cancer
CA2225185A1 (en) 1997-08-11 1999-02-11 Peter K. Law Myoblast transfer therapy for relieving pain and for treating behavioral and perceptive abnormalities
US6316414B1 (en) 2000-07-31 2001-11-13 Dabur Research Foundation Somatostatin analogs for the treatment of cancer
WO2008090114A1 (en) 2007-01-24 2008-07-31 Glaxo Group Limited Pharmaceutical compositions comprising 2-methoxy-5- (5-trifluoromethyl-tetrazol-i-yl-benzyl) - (2s-phenyl-piperidin-3s-yl-)
CN102612373B (zh) * 2009-11-11 2016-03-02 国立大学法人山口大学 消化器官疾病治疗剂
US9446029B2 (en) 2010-07-27 2016-09-20 Colorado State University Research Foundation Use of NK-1 receptor antagonists in management of visceral pain
EP4466005A1 (en) * 2022-01-21 2024-11-27 Institut Pasteur De Montevideo Active immunization for reducing osteoarthritic, neuropathic, and cancer pain

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862114A (en) * 1971-11-22 1975-01-21 Ici Australia Ltd Analogs of substance p
IT1212508B (it) * 1981-12-22 1989-11-22 Anic Spa Analoghi retro - invertiti dei penta - ed esapeptidi c - terminali della sostanza p. utili come vasodilatatori
US4481139A (en) * 1983-04-13 1984-11-06 Board Of Regents, The University Of Texas System Peptide antagonists of substance P
US4803261A (en) * 1986-06-27 1989-02-07 The Administrators Of The Tulane Educational Fund Method for synthesizing a peptide containing a non-peptide
ZA894533B (en) * 1988-06-20 1990-03-28 Merrell Dow Pharma Neurokinin a antogonists

Also Published As

Publication number Publication date
IE902958A1 (en) 1991-02-27
DD298411A5 (de) 1992-02-20
JPH04502922A (ja) 1992-05-28
CZ285319B6 (cs) 1999-07-14
EP0438566A4 (en) 1993-03-31
GR900100613A (el) 1991-12-30
IE77033B1 (en) 1997-11-19
EP0438566B1 (en) 1996-09-25
WO1991002745A1 (en) 1991-03-07
SK280796B6 (sk) 2000-07-11
DE69028692T2 (de) 1997-02-20
DE69028692D1 (de) 1996-10-31
CA2039175A1 (en) 1991-02-17
ES2094160T3 (es) 1997-01-16
PT95016A (pt) 1991-04-18
PT95016B (pt) 1997-05-28
EP0438566A1 (en) 1991-07-31
SK402890A3 (en) 2000-07-11
HUT65465A (en) 1994-06-28
ATE143372T1 (de) 1996-10-15
HU906872D0 (en) 1991-07-29
CZ285562B6 (cs) 1999-09-15
CZ402890A3 (cs) 1999-04-14

Similar Documents

Publication Publication Date Title
ATE139540T1 (de) Heilmittelpeptide
DK249489A (da) Therapeutisk virksomme peptider, isaer bombesinantagonistiske og litorinantagonistiske peptider samt fremgangsmaade til fremstilling deraf
DE69028692D1 (de) Substance P Antagoniste
DK66391A (da) Terapeutisk virksomme peptider
DE69011102D1 (de) Hydrophobe bindungsstelle für adhäsionspeptide.
ATE189526T1 (de) Verfahren zum nachweis von aktiven domänen und aminosäureresten in polypeptiden und hormonvarianten
ES2124685T3 (es) Variantes del inhibidor de la tripsina pancreatica bovina, su produccion y uso.
DE3750197D1 (de) Antagonisten des Fibroblasten-Wachstumsfaktors.
ATE201696T1 (de) Zyklische peptidanaloga von somatostatin
ES2124247T3 (es) Conjugado de calcitonina y de polietilenglicol.
MX9203175A (es) Composicion de implante que contiene un peptido, polipeptido o proteina biologicamente activa y procedimiento para su preparacion.
DE69528531D1 (de) D-2-alkyltryptophan enthaltende polypeptide mit wachstumhormon freisetzender aktivitaet
ES2100960T3 (es) Estructura proteica de la toxina vegetal gelonina.
ATE129744T1 (de) Rekombinantes c-terminal alpha amidatierungsenzym von menschlischem thyroidursprung.
PT93320A (pt) Processo para a preparacao de peptideos terapeuticos
DE3869939D1 (de) Biologisch wirksame peptide.
DE3665462D1 (en) Pharmacologically active peptides
PT95057A (pt) Processo para a preparacao de peptidos terapeuticos
IT1274359B (it) Peptide sintetico ad attivita' antagonistica per la proteina chemiotattica dei monociti 1 (mcp-1)